26th Sep 2024 14:00
Dr. Martens plc
Notification of transaction by Person Closely Associated with a PDMR
Dr. Martens plc (the ‘Company’) announces that on 26 September 2024 the following transaction in the Company’s ordinary shares was undertaken by a person closely associated with a director / person discharging managerial responsibility (‘PDMR’).
The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
1. | Details of PDMR / person closely associated with them | |||||
a) | Name | Katie Wilson | ||||
2. | Reasons for the notification | |||||
a) | Position / status | Person Closely Associated with Giles Wilson, Chief Financial Officer and PDMR | ||||
b) | Initial notification / amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Full name of the entity | Dr. Martens plc | ||||
b) | Legal Entity Identifier code | 213800QPT8YM6NQZPH28 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares of GBP 0.01 each ISIN: GB00BL6NGV24 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price |
N/A – single transaction | ||||
e) | Date of the transaction | 26 September 2024 | ||||
f) | Place of the transaction | London Stock Exchange (XLON) | ||||
Related Shares:
Dr. Martens